Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06250322
Other study ID # PCOL204APME
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 10, 2024
Est. completion date March 1, 2025

Study information

Verified date April 2024
Source Johnson & Johnson Surgical Vision, Inc.
Contact Study Contact
Phone +49 170 7804891
Email mfaust@its.jnj.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Ambispective post-market data collection on visual symptoms, patient satisfaction and surgeon experience with the TECNIS PC IOL.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date March 1, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients who are bilaterally implanted with TECNIS PC IOL and are at least 45 days postoperative from their second eye surgery - Clear intraocular media - Signed informed consent and data protection documentation - Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures - Ability to understand, read, and write English or the local language in which the informed consent and questionnaires are provided Exclusion Criteria: - Subjects with ongoing adverse events that might impact outcomes during the study - Use of systemic or ocular medication that may affect vision - Acute or chronic disease or condition, ocular trauma or surgery that may confound results - Patients with amblyopia, strabismus, nystagmus - Concurrent participation in another clinical trial

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intervention
No study treatments will be administered during this study. However, data will be collected from medical records of patients who have been treated with the subject device of this study.

Locations

Country Name City State
Austria Vienna Institute for Research in Ocular Surgery - A Karl-Landsteiner-Institute Vienna
France CHU Morvan Brest Brest
France Clinique Juge Marseille Marseille
Germany Augenklinik Ahaus GmbH & Co. KG Ahaus
Germany Augenklinik Dardenne Bonn
Korea, Republic of Kim's eye clinic Seoul
Korea, Republic of Korea Uni.Kuro Seoul
Netherlands Oogziekenhuis Rotterdam Rotterdam
Netherlands ETZ Tilburg
Spain Clinica Oftalmologica Diez del Corral Madrid
Spain Mirzana IOA Madrid
Spain Vithas Alicante Madrid

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Surgical Vision, Inc.

Countries where clinical trial is conducted

Austria,  France,  Germany,  Korea, Republic of,  Netherlands,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Symptoms Patient questionnaires 3month postoperative
Primary Surgeon Experience Questionnaire 3month postoperative
Primary Visual Acuity Visual Acuity will be collected with standard clinical charts. 3month postoperative
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06005675 - User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL
Active, not recruiting NCT01382641 - Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract Surgery Phase 4
Completed NCT01382823 - Laser Cataract Surgery With the Femtosecond Laser Technology Phase 4
Completed NCT05991960 - Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL
Active, not recruiting NCT05574959 - Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00V N/A
Completed NCT02492659 - Clinical Research of Femtosecond Laser-Assisted Cataract Surgery N/A
Completed NCT01279031 - Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial Phase 4
Completed NCT01001806 - A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification Phase 4
Completed NCT01021761 - A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification Phase 4
Completed NCT00999492 - Selection of Aspheric Diffractive Multifocal Intraocular Lens (IOLS) Based on Corneal Wavefront Phase 4
Completed NCT01061463 - Occupational Cataracts and Lens Opacities in Interventional Cardiology : the O'CLOC Study N/A
Completed NCT00542581 - Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D. N/A
Completed NCT03708367 - A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice N/A
Completed NCT05575063 - Clinical Investigation of Healon EndoCoat Ophthalmic Viscosurgical Device (OVD) N/A
Recruiting NCT05531292 - PROOF-OF-CONCEPT STUDY FOR NEW INTRAOCULAR LENS, MODEL C0002 N/A
Completed NCT05058274 - Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens With Plate Haptics in Hyperopic Eyes (HIPER-AT-TORBI)
Completed NCT05053399 - Evaluation of the TECNIS Symfony® Toric Intraocular Lens N/A
Recruiting NCT02639845 - Eye Drop Application Monitor, Pilot Study N/A
Completed NCT01684007 - A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients N/A
Completed NCT00827073 - Comparison of Tetracaine 0.5% and Lidocaine 2% Jelly for Topical Phacoemulsification Cataract Surgery N/A